no_image_available

Prohibited List - SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION

SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION

In addition to the categories S0 to S5 and M1 to M3 defined above, the following categories are prohibited In-Competition:

**** PROHIBITED SUBSTANCES

**** S6. STIMULANTS

PROHIBITED IN-COMPETITION

All prohibited substances in this class are Specified Substancesexcept those in S6.A, which are non*-Specified Substances*.

Substances of Abusein this section: cocaine and methylenedioxymethamphetamine (MDMA / “ecstasy”)

All stimulants, including all optical isomers, e.g. d*-* and l*-* where relevant, are prohibited.

Stimulants include:

S6.A: Non-Specified Stimulants:

  • Adrafinil
  • Amfepramone
  • Amfetamine
  • Amfetaminil
  • Amiphenazole
  • Benfluorex
  • Benzylpiperazine
  • Bromantan
  • Clobenzorex
  • Cocaine
  • Cropropamide
  • Crotetamide
  • Fencamine
  • Fenetylline
  • Fenfluramine
  • Fenproporex
  • Fonturacetam [4-phenylpiracetam (carphedon)]
  • Furfenorex
  • Hydrafinil (fluorenol)
  • Lisdexamfetamine
  • Mefenorex
  • Mephentermine
  • Mesocarb
  • Metamfetamine(d-)
  • p-methylamfetamine
  • Modafinil
  • Norfenfluramine
  • Phendimetrazine
  • Phentermine
  • Prenylamine

A stimulant not expressly listed in this section is a Specified Substance.

S6.B: Specified Stimulants.

Including, but not limited to:

  • 2-phenylpropan-1-amine (ß-methylphenylethyl[1]amine, BMPEA)
  • 3-Methylhexan-2-amine (1,2-dimethylpentylamine)
  • 4-Fluoromethylphenidate
  • 4-Methylhexan-2-amine (1,3-dimethylamylamine, 1,3 DMAA, methylhexanea[1]mine)
  • 4-Methylpentan-2-amine (1,3-dimethylbutylamine)
  • 5-Methylhexan-2-amine (1,4-dimethylamylamine, 1,4-dimethylpentylamine, 1,4-DMAA)
  • Benzfetamine
  • Cathine**
  • Cathinone and its ana[1]logues, e.g. mephedrone, methedrone, and ɑ - pyrrolidinovalerophenone
  • Dimetamfetamine (dimethylamphetamine)
  • Ephedrine***
  • Epinephrine**** (adrenaline)
  • Etamivan
  • Ethylphenidate
  • Etilamfetamine
  • Etilefrine
  • Famprofazone
  • Fenbutrazate
  • Fencamfamin
  • Heptaminol
  • Hydroxyamfetamine (parahydroxyamphet-amine)
  • Isometheptene
  • Levmetamfetamine
  • Meclofenoxate
  • Methylenedioxymetham-phetamine
  • Methylephedrine***
  • Methylnaphthidate [(±)-methyl-2-(naphthalen-2- yl)-2-(piperidin-2-yl)acetate]
  • Methylphenidate
  • Midodrine
  • Nikethamide
  • Norfenefrine
  • Octodrine (1,5-dimethyl[1]hexylamine)
  • Octopamine
  • Oxilofrine (methylsynephrine)
  • Pemoline
  • Pentetrazol
  • Phenethylamine and its derivatives
  • Phenmetrazine
  • Phenpromethamine
  • Propylhexedrine
  • Pseudoephedrine*****
  • Selegiline
  • Sibutramine
  • Solriamfetol
  • Strychnine
  • Tenamfetamine (methylenedioxyamphet-amine)
  • Tesofensine
  • Tuaminoheptane

and other substances with a similar chemical structure or similar biological effect(s).

Except:

  • Clonidine, guanfacine;
  • Imidazoline derivatives for dermatological, nasal, ophthalmic or otic use (e.g. brimonidine, clonazoline, fenoxazoline, indanazoline, naphazoline, oxymetazoline, tetryzoline, tramazoline, xylometazoline) and those stimulants included in the 2025 Monitoring Program*

* Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are included in the 2025 Monitoring Program and are not considered Prohibited Substances.

** Cathine (d-norpseudoephedrine) and its l-isomer: Prohibited when its concentration in urine is greater than 5 micrograms per millilitre.

*** Ephedrine and methylephedrine: Prohibited when the concentration of either in urine is greater than 10 micrograms per millilitre.

**** Epinephrine (adrenaline): Not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration with local anaesthetic agents.

***** Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 micrograms per millilitre.

**** S7. NARCOTICS

PROHIBITED IN-COMPETITION

All prohibited substances in this class are Specified Substances.

Substance of Abuse in this section: diamorphine (heroin)

The following narcotics, including all optical isomers, e.g. d- and l- where relevant, are prohibited.

  • Buprenorphine
  • Dextromoramide
  • Diamorphine (heroin)
  • Fentanyl and its derivatives
  • Hydromorphone
  • Methadone
  • Morphine
  • Nicomorphine
  • Oxycodone
  • Oxymorphone
  • Pentazocine
  • Pethidine
  • Tramadol

S8. CANNABINOIDS

All prohibited substances in this class are Specified Substances.

Substance of Abusein this section: tetrahydrocannabinol (THC)

All natural and synthetic cannabinoids are prohibited, e.g.

  • In cannabis (hashish, marijuana) and cannabis products
  • Natural and synthetic tetrahydrocannabinols (THCs)
  • Synthetic cannabinoids that mimic the effects of THC

Except:

Cannabidiol

S9. GLUCOCORTICOIDS

All prohibited substances in this class are Specified Substances.

All glucocorticoids are prohibited when administered by any injectable, oral [including oromucosal (e.g. buccal, gingival, sublingual)] or rectal route.

Including but not limited to:

Including, but not limited to:

  • Beclometasone
  • Betamethasone
  • Budesonide
  • Ciclesonide
  • Cortisone
  • Deflazacort
  • Dexamethasone
  • Flunisolide
  • Fluocortolone
  • Fluticasone
  • Hydrocortisone
  • Methylprednisolone
  • Mometasone
  • Prednisolone
  • Prednisone
  • Triamcinolone acetonide

NOTE:

  • Other routes of administration (including inhaled, and topical: dental-intracanal, dermal, intranasal, ophthalmological, otic and perianal) are not prohibited when used within the manufacturer’s licensed doses and therapeutic indications.